Breakthrough findings for the treatment of heart attack patients with cardiogenic shock

October 11, 2018, CORDIS
Breakthrough findings for the treatment of heart attack patients with cardiogenic shock
Credit: ARTTIC S.A.S.

Heart attacks with cardiogenic shock represent a major European healthcare concern with mortality rates between 40-70 percent. So how can it be treated best? The breakthrough findings of the five-year long CULPRIT-SHOCK multi-center study give a clear answer to this question and even lead to a change of the Guidelines of the European Society of Cardiology.

Cardiogenic shock complicating acute (AMI) represents a major European healthcare concern with between 40-70 percent. The clinician is faced with the decision to either intervene only on the culprit lesion acutely responsible for the initiation of cardiogenic shock, or treat additional lesions considered hemodynamically significant but not acutely triggering the shock cascade as well.

Credit: ARTTIC S.A.S.

Current guidelines recommend (PCI) of all critical lesions. However, due to a lack of randomized trials, these recommendations are solely based on registry data and pathophysiological considerations. The aim of the randomized CULPRIT-SHOCK trial has therefore been to compare immediate multivessel PCI versus culprit-lesion-only PCI in patients with AMI complicated by cardiogenic shock.

Credit: ARTTIC S.A.S.

For the study, a total of 706 cardiogenic shock patients have been randomized in 11 European countries. CULPRIT-SHOCK clarified the role of different percutaneous revascularization strategies in patients with cardiogenic shock secondary to myocardial infarction and multivessel disease. CULPRIT-SHOCK is now the largest randomized controlled clinical trial in patients with cardiogenic shock ever conducted and will inform patients, healthcare providers, and decision-makers about which percutaneous revascularization strategy is most effective.

Credit: ARTTIC S.A.S.

Explore further: Should patients with cardiogenic shock receive culprit lesion only PCI or multivessel PCI?

Related Stories

Should patients with cardiogenic shock receive culprit lesion only PCI or multivessel PCI?

October 31, 2017
Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found that an initial strategy of culprit lesion only percutaneous coronary intervention (PCI) reduces the composite of 30-day mortality and/or severe ...

Six variables can predict mortality risk in cardiogenic shock

April 14, 2017
(HealthDay)—Six variables can be combined to predict short-term mortality risk in patients with cardiogenic shock (CS), according to a study published in the April 18 issue of the Journal of the American College of Cardiology.

Successful cardiogenic shock treatment using a percutaneous left ventricular assist device

October 31, 2017
The Cardiovascular Surgery Group at Osaka University succeeded in minimally invasive treatment of a patient with acute heart failure due to medical treatment-resistant cardiogenic shock by making use of Impella, a percutaneous ...

Intraaortic balloon pump fails to improve mortality rate in cardiogenic shock patients: The IABP-SHOCK II study

August 27, 2012
A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in several million people. However, there is still ...

Heart attack patients with cardiogenic shock fair well 60 days post-discharge

February 15, 2016
Heart attack patients who experience cardiogenic shock have a higher risk of death or rehospitalization than non-shock patients in the first 60 days post-discharge, but by the end of the first year, the gap between the two ...

Patient-level model predicts in-hospital mortality in acute MI

August 4, 2016
(HealthDay)—A parsimonious patient-level clinical risk model can predict in-hospital mortality for patients with acute myocardial infarction, according to a study published in the Aug. 9 issue of the Journal of the American ...

Recommended for you

No sweat required: Team finds hypertension treatment that mimics effect of exercise

October 16, 2018
Couch potatoes rejoice—there might be a way to get the blood pressure lowering benefits of exercise in pill form.

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Why heart contractions are weaker in those with hypertrophic cardiomyopathy

October 16, 2018
When a young athlete suddenly dies of a heart attack, chances are high that they suffer from familial hypertrophic cardiomyopathy (HCM). Itis the most common genetic heart disease in the US and affects an estimated 1 in 500 ...

Novel genetic study sheds new light on risk of heart attack

October 12, 2018
Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.

Researchers say ritual for orthodox Jewish men may offer heart benefits

October 11, 2018
A pilot study led by researchers at the University of Cincinnati (UC) College of Medicine suggests Jewish men who practice wearing tefillin, which involves the tight wrapping of an arm with leather banding as part of daily ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

aaronpaul456
not rated yet Oct 12, 2018
Heart Valve Therapy is a dedicated interventional cardiologist with experience in both adult, pediatric and peripheral interventions. He is capable of performing TAVI, left atrial appendage closures, renal artery denervation apart from complex coronary and pediatric structural heart disease interventions. He also performs carotid and aorto-iliac interventions including intervention for aortic aneurysm and dissections.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.